Kezar Life Sciences IncNASDAQ:KZRNASDAQ FSI:D. Deficient (Issuer failed to meet continued listing requirements)
- LAST PRICE0.5700
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots0.5596/ 20
- Ask / Lots0.5980/ 1
- Open / Previous Close0.0000 / 0.5700
- Day Range---
- 52 Week Range
- Volume---
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | KZR |
|---|---|---|
| 09:32 ET | 5188 | 0.58 |
| 09:34 ET | 600 | 0.58 |
| 09:36 ET | 800 | 0.58 |
| 09:38 ET | 9711 | 0.571 |
| 09:39 ET | 2513 | 0.57 |
| 09:41 ET | 7800 | 0.576 |
| 09:43 ET | 3980 | 0.58 |
| 09:45 ET | 3500 | 0.58 |
| 09:48 ET | 7778 | 0.585 |
| 09:50 ET | 112789 | 0.54 |
| 09:52 ET | 29028 | 0.5631 |
| 09:54 ET | 8886 | 0.5687 |
| 09:56 ET | 1750 | 0.5758 |
| 09:57 ET | 440 | 0.5735 |
| 09:59 ET | 4057 | 0.5774 |
| 10:01 ET | 3067 | 0.5811 |
| 10:06 ET | 540 | 0.5816 |
| 10:08 ET | 340 | 0.5816 |
| 10:10 ET | 1769 | 0.5816 |
| 10:12 ET | 1285 | 0.5814 |
| 10:14 ET | 1413 | 0.5801 |
| 10:15 ET | 823 | 0.5814 |
| 10:17 ET | 11940 | 0.5795 |
| 10:19 ET | 2738 | 0.5794 |
| 10:21 ET | 810 | 0.57975 |
| 10:24 ET | 1332 | 0.5778 |
| 10:26 ET | 1201 | 0.5793 |
| 10:28 ET | 2235 | 0.5793 |
| 10:30 ET | 620 | 0.5793 |
| 10:32 ET | 1560 | 0.5778 |
| 10:33 ET | 1240 | 0.5789 |
| 10:35 ET | 1763 | 0.5774 |
| 10:37 ET | 2170 | 0.57855 |
| 10:39 ET | 500 | 0.5785 |
| 10:42 ET | 500 | 0.57855 |
| 10:44 ET | 4536 | 0.5798 |
| 10:46 ET | 300 | 0.5798 |
| 10:48 ET | 1295 | 0.5798 |
| 10:50 ET | 300 | 0.57975 |
| 10:51 ET | 5599 | 0.57985 |
| 10:53 ET | 768 | 0.5799 |
| 10:55 ET | 2088 | 0.57975 |
| 10:57 ET | 1058 | 0.57975 |
| 11:00 ET | 1800 | 0.57975 |
| 11:02 ET | 1200 | 0.57975 |
| 11:04 ET | 1835 | 0.5798 |
| 11:06 ET | 1200 | 0.57975 |
| 11:08 ET | 1183 | 0.57975 |
| 11:09 ET | 675 | 0.5798 |
| 11:11 ET | 1708 | 0.5797 |
| 11:13 ET | 400 | 0.5797 |
| 11:15 ET | 1986 | 0.57975 |
| 11:18 ET | 1004 | 0.5798 |
| 11:20 ET | 1100 | 0.57975 |
| 11:22 ET | 1482 | 0.5798 |
| 11:24 ET | 1667 | 0.57965 |
| 11:26 ET | 1274 | 0.5798 |
| 11:27 ET | 1400 | 0.57975 |
| 11:29 ET | 2086 | 0.5798 |
| 11:31 ET | 14670 | 0.5797 |
| 11:33 ET | 8491 | 0.5797 |
| 11:36 ET | 3874 | 0.5798 |
| 11:38 ET | 1600 | 0.5798 |
| 11:40 ET | 5850 | 0.57975 |
| 11:42 ET | 4925 | 0.57975 |
| 11:44 ET | 5103 | 0.5798 |
| 11:45 ET | 11354 | 0.5797 |
| 11:47 ET | 2982 | 0.5798 |
| 11:49 ET | 1500 | 0.5798 |
| 11:51 ET | 632 | 0.5797 |
| 11:54 ET | 903 | 0.57965 |
| 11:56 ET | 780 | 0.57965 |
| 11:58 ET | 2869 | 0.5797 |
| 12:00 ET | 955 | 0.5796 |
| 12:02 ET | 3554 | 0.5796 |
| 12:03 ET | 300 | 0.57955 |
| 12:05 ET | 3200 | 0.57645 |
| 12:07 ET | 400 | 0.5771 |
| 12:09 ET | 700 | 0.5782 |
| 12:12 ET | 700 | 0.5781 |
| 12:14 ET | 500 | 0.5781 |
| 12:16 ET | 1600 | 0.57705 |
| 12:18 ET | 400 | 0.5769 |
| 12:20 ET | 421 | 0.5778 |
| 12:21 ET | 800 | 0.5769 |
| 12:23 ET | 5744 | 0.5769 |
| 12:25 ET | 1700 | 0.57685 |
| 12:27 ET | 1223 | 0.5777 |
| 12:30 ET | 800 | 0.5777 |
| 12:32 ET | 306 | 0.57685 |
| 12:34 ET | 5650 | 0.5769 |
| 12:36 ET | 500 | 0.5778 |
| 12:38 ET | 300 | 0.5778 |
| 12:39 ET | 2080 | 0.5778 |
| 12:41 ET | 300 | 0.5778 |
| 12:43 ET | 1100 | 0.57695 |
| 12:45 ET | 200 | 0.57695 |
| 12:48 ET | 12686 | 0.5769 |
| 12:50 ET | 1620 | 0.57685 |
| 12:52 ET | 422 | 0.57685 |
| 12:54 ET | 200 | 0.57685 |
| 12:56 ET | 4665 | 0.57685 |
| 12:57 ET | 313 | 0.57685 |
| 12:59 ET | 300 | 0.5777 |
| 01:01 ET | 7405 | 0.5762 |
| 01:03 ET | 532 | 0.5762 |
| 01:06 ET | 628 | 0.5774 |
| 01:08 ET | 943 | 0.5767 |
| 01:10 ET | 20092 | 0.57605 |
| 01:12 ET | 880 | 0.5765 |
| 01:14 ET | 466 | 0.577 |
| 01:15 ET | 7813 | 0.5754 |
| 01:17 ET | 300 | 0.5729 |
| 01:19 ET | 3902 | 0.57265 |
| 01:21 ET | 300 | 0.5751 |
| 01:24 ET | 500 | 0.5747 |
| 01:26 ET | 700 | 0.57 |
| 01:28 ET | 2968 | 0.57 |
| 01:30 ET | 5522 | 0.5739 |
| 01:32 ET | 940 | 0.5736 |
| 01:33 ET | 400 | 0.5736 |
| 01:35 ET | 400 | 0.571 |
| 01:37 ET | 973 | 0.57 |
| 01:39 ET | 200 | 0.5733 |
| 01:42 ET | 1349 | 0.57 |
| 01:44 ET | 1455 | 0.57 |
| 01:46 ET | 300 | 0.5729 |
| 01:48 ET | 5713 | 0.5714 |
| 01:50 ET | 400 | 0.5724 |
| 01:51 ET | 400 | 0.57105 |
| 01:53 ET | 11120 | 0.5685 |
| 01:55 ET | 250 | 0.5699 |
| 01:57 ET | 700 | 0.5678 |
| 02:00 ET | 894 | 0.568 |
| 02:02 ET | 300 | 0.568 |
| 02:04 ET | 600 | 0.5697 |
| 02:06 ET | 700 | 0.5698 |
| 02:08 ET | 828 | 0.5697 |
| 02:09 ET | 669 | 0.56975 |
| 02:11 ET | 2100 | 0.5697 |
| 02:13 ET | 300 | 0.5689 |
| 02:15 ET | 300 | 0.56885 |
| 02:18 ET | 300 | 0.5688 |
| 02:20 ET | 6305 | 0.5678 |
| 02:22 ET | 305 | 0.5676 |
| 02:24 ET | 900 | 0.5671 |
| 02:26 ET | 1200 | 0.56725 |
| 02:27 ET | 6482 | 0.5673 |
| 02:29 ET | 1961 | 0.5673 |
| 02:31 ET | 100 | 0.56715 |
| 02:33 ET | 2921 | 0.56715 |
| 02:36 ET | 2287 | 0.567 |
| 02:38 ET | 14377 | 0.5667 |
| 02:40 ET | 49774 | 0.5743 |
| 02:42 ET | 300 | 0.5743 |
| 02:45 ET | 887 | 0.571 |
| 02:47 ET | 300 | 0.5726 |
| 02:49 ET | 4726 | 0.5726 |
| 02:51 ET | 889 | 0.5742 |
| 02:54 ET | 1075 | 0.5742 |
| 02:56 ET | 1500 | 0.5741 |
| 02:58 ET | 768 | 0.571 |
| 03:00 ET | 1400 | 0.571 |
| 03:02 ET | 3400 | 0.574 |
| 03:03 ET | 396 | 0.5737 |
| 03:05 ET | 3484 | 0.5737 |
| 03:07 ET | 1192 | 0.5733 |
| 03:09 ET | 5120 | 0.5733 |
| 03:12 ET | 3886 | 0.5732 |
| 03:16 ET | 1801 | 0.5714 |
| 03:18 ET | 600 | 0.5711 |
| 03:20 ET | 1700 | 0.5711 |
| 03:21 ET | 1734 | 0.56925 |
| 03:23 ET | 2006 | 0.569 |
| 03:25 ET | 5217 | 0.5711 |
| 03:27 ET | 7081 | 0.5739 |
| 03:30 ET | 37549 | 0.5703 |
| 03:32 ET | 15351 | 0.57395 |
| 03:34 ET | 1700 | 0.5771 |
| 03:36 ET | 2800 | 0.5766 |
| 03:38 ET | 835 | 0.5748 |
| 03:39 ET | 3714 | 0.5709 |
| 03:41 ET | 2600 | 0.5741 |
| 03:43 ET | 5698 | 0.5739 |
| 03:45 ET | 4562 | 0.5717 |
| 03:48 ET | 2850 | 0.5711 |
| 03:50 ET | 1000 | 0.5714 |
| 03:52 ET | 6156 | 0.5709 |
| 03:54 ET | 5920 | 0.571 |
| 03:56 ET | 4709 | 0.5716 |
| 03:57 ET | 19818 | 0.5725 |
| 03:59 ET | 55643 | 0.57 |
Jun 7, 2024
Kezar Announces Inducement Grant Under NASDAQ Listing Rule 5635(c)(4), from 5:59PM ET on Friday Jun 07, 2024 by Dow Jones
5:59PM ET on Friday Jun 07, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Kezar Life Sciences Inc | 41.5M | -0.4x | --- |
LAVA Therapeutics NV | 49.7M | -1.8x | --- |
DURECT Corp | 42.2M | -1.6x | --- |
Atara Biotherapeutics Inc | 36.9M | -0.1x | --- |
Evogene Ltd | 33.9M | -1.5x | --- |
Correlate Energy Corp | 26.1M | -1.7x | --- |
Company Information
Kezar Life Sciences, Inc. is a clinical-stage biopharmaceutical company focused on discovering and developing small molecule therapeutics to treat unmet needs in immune-mediated diseases and cancer. The Company's lead product candidate, zetomipzomib, is a first-in-class selective immunoproteasome inhibitor that has completed Phase Ia testing in healthy volunteers and a Phase Ib/IIa clinical trial in patients with systemic lupus erythematosus (SLE), with or without lupus nephritis (LN). Its oncology product candidate, KZR-261, is a small molecule agent, targeting the Sec61 translocon and protein secretion pathway, being studied in an open-label Phase I clinical trial designed to evaluate safety and tolerability, pharmacokinetics and pharmacodynamics, as well to explore preliminary anti-tumor activity. This study is being conducted in two parts: dose escalation in patients with locally advanced or metastatic solid malignancies, and dose expansion in patients with selected tumor types.
Contact Information
- Headquarters
- 4000 Shoreline Ct Ste 300SOUTH SAN FRANCISCO, CA, United States 94080-2005
- Phone
- 650-822-5600
- Fax
- 302-636-5454
Executives
- Independent Chairman of the Board
- Graham Cooper
- Chief Executive Officer, Director
- Christopher Kirk
- Chief Financial Officer, Secretary
- Marc Belsky
- Chief Business Officer
- Nick Mordwinkin
- Chief Legal Officer
- Mark Schiller
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $41.5M |
|---|---|
Revenue (TTM) | $7.0M |
Shares Outstanding | 72.8M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.28 |
EPS | $-1.40 |
Book Value | $2.58 |
P/E Ratio | -0.4x |
Price/Sales (TTM) | 5.9 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -1,591.77% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
